Edward Y Kim
Overview
Explore the profile of Edward Y Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wallner K, Kearney K, Azzalini L, Kim E, Parvathaneni U, Sandison G, et al.
Brachytherapy
. 2024 Dec;
24(1):103-109.
PMID: 39658407
Introduction: There is some evidence of a dose-response relationship for intravascular brachytherapy (IVBT) of native vessel or first-time in-stent restenosis (ISR). It has also been shown that in-field failure predominates...
2.
Wallner K, Kearney K, Tiwana J, Pristera N, Kim E, Azzalini L, et al.
Catheter Cardiovasc Interv
. 2023 Oct;
102(6):1034-1039.
PMID: 37855145
Background: Most randomized studies testing the effectiveness of IVBT were limited to vessels less than 4 mm diameter. In fact, it is now common to treat vessels larger than 4...
3.
Seo Y, Lu H, Black G, Smythe K, Yu Y, Hsu C, et al.
JAMA Oncol
. 2023 Oct;
9(12):1660-1668.
PMID: 37824131
Importance: Metastatic soft tissue sarcomas (STSs) have limited systemic therapy options, and immunomodulation has not yet meaningfully improved outcomes. Intratumoral (IT) injection of the toll-like receptor 4 (TLR4) agonist glycopyranosyl...
4.
Chau B, Loggers E, Cranmer L, Mogal H, Sharib J, Kim E, et al.
Am J Clin Oncol
. 2023 Sep;
46(12):567-571.
PMID: 37725702
Objectives: Angiosarcoma is a rare complication of breast-conserving therapy. This study evaluated the change in incidence between 1992 and 2016 of secondary breast angiosarcoma (SBA) in patients with a history...
5.
Wallner K, Kearney K, Tiwana J, Pristera N, Kim E, Sandison G, et al.
Cardiovasc Revasc Med
. 2023 Sep;
59:29-34.
PMID: 37684192
Purpose: To evaluate coronary artery integrity after very high radiation doses from intravascular brachytherapy (IVBT) in the setting of source asymmetry. Methods: Ten patients treated for right coronary artery (RCA)...
6.
Lussier L, Wallner K, Kearney K, Tiwana J, Kim E, Parvathaneni U, et al.
Brachytherapy
. 2023 May;
22(4):518-523.
PMID: 37211487
Purpose: Coronary stents reduce IVBT radiation dose with a single layer by 10-30%. However, the impact of multiple stent layers and stent expansion remains unexplored. Individualized dose adjustments considering variations...
7.
Wallner K, Kearney K, Kim M, Tiwana J, Elison D, Kim E, et al.
Catheter Cardiovasc Interv
. 2022 Sep;
100(5):759-762.
PMID: 36098336
Introduction: One strategy to improve the effectiveness of intravascular brachytherapy (IVBT) is to study its failures. Previous investigations described mostly discrete, focal recurrences, typically at the proximal or distal edges...
8.
Schaub S, Kim E
Int J Radiat Oncol Biol Phys
. 2022 Mar;
112(5):1071-1072.
PMID: 35286876
No abstract available.
9.
Goff P, Riolobos L, LaFleur B, Spraker M, Seo Y, Smythe K, et al.
Clin Cancer Res
. 2022 Feb;
28(8):1701-1711.
PMID: 35115306
Purpose: To characterize changes in the soft-tissue sarcoma (STS) tumor immune microenvironment induced by standard neoadjuvant therapy with the goal of informing neoadjuvant immunotherapy trial design. Experimental Design: Paired pre-...
10.
Cranmer L, Chau B, Mantilla J, Loggers E, Pollack S, Kim T, et al.
Clin Orthop Relat Res
. 2021 Oct;
480(4):748-758.
PMID: 34648466
Background: Dedifferentiated chondrosarcoma is a chondrosarcoma subtype associated with high rates of recurrence and a poor prognosis. Others have proposed treatment of dedifferentiated chondrosarcoma using osteosarcoma protocols, including perioperative chemotherapy....